BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Six-month interim report (Q2) 2023

  ALK’s revenue grew by 11% in Q2 2023, driven by 17% growth in tablet sales and double-digit growth in combined SCIT/SLIT-drops sales.

  August 24, 2023

   · 

  3 min read
• Pharming Group to participate in September 2023 investor conferences

  Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September.

  August 24, 2023

   · 

  2 min read
• Business

  111, Inc. Announces Second Quarter 2023 Unaudited Financial Results

  111, Inc., a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, announced its unaudited financial results for the second quarter ended June 30, 2023.

  August 24, 2023

   · 

  21 min read
• Business

  AlzeCure Publishes its Interim Report for January – June 2023

  AlzeCure Pharma AB announced that its interim report for the period January - June 2023 is now available on the company’s website.

  August 24, 2023

   · 

  4 min read
• XNK Therapeutics enters into research collaboration with Karolinska University Hospital in acute myeloid leukemia (AML)

  XNK Therapeutics AB announced that the company has entered into a research collaboration with the Karolinska University Hospital, Sweden, to evaluate the suitability of the company’s autologous natural killer cell therapy candidate XNK02 as a novel therapy for treatment of acute myeloid leukemia.

  August 24, 2023

   · 

  3 min read
• BioMidwest

  CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Physician-Scientist

  CancerVAX, Inc announced that in a recent Company podcast its CEO, Ryan Davies, spoke with and UCLA cancer physician and researcher, Dr. Steven Jonas, about his journey to becoming both a practicing cancer doctor and active cancer researcher.

  August 24, 2023

   · 

  3 min read
• Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023

  Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help improve clinical confidence and increase efficiency.

  August 24, 2023

   · 

  3 min read
• Policy

  European Medicines Agency Accepts Novaliq’s Marketing Authorization Application for CyclASol® (ciclosporin ophthalmic solution) 0.1% for the Treatment of Dry Eye Disease

  Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced that the European Medicines Agency has accepted the marketing authorization application for CyclASol for regulatory review.

  August 24, 2023

   · 

  3 min read
• Biovica Announces the Start of a DiviTum(R) TKa Clinical Trial

  Biovica International, active in cancer diagnostics, announces the initiation of a prospective clinical trial to study the correlation between DiviTum TKa levels and the effects of medication dose reductions in the care of metastatic breast cancer patients.

  August 24, 2023

   · 

  3 min read
• Business

  Synthego and bit.bio Expand Strategic Partnership to Build a Platform for the Development of Safer and More Efficient Genetic Engineering of Human Cells for Cell Therapies

  Synthego and bit.bio announced a strategic partnership to build a platform centered on the implementation of synthetic circuitry in cells for therapeutic application.

  August 24, 2023

   · 

  4 min read